source
- Eli Lilly inks $5.9 billion partnership with Stipple Bio to develop precision oncology drugsEli Lilly has announced a partnership with Stipple Bio that could be worth up to $5.9 billion. The collaboration will focus on oncology drug candidates designed to target tumor cells more precisely…
- Marrow raises $173M for siRNA drug competing with CRISPR therapy for sickle cellWhen the FDA approved two gene therapies for sickle cell disease in December 2023, many drugmakers viewed it as the end of the story and shelved their programs for the condition. Yet three years on…Endpoints · 1h ago↗ source